Literature DB >> 27226569

Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE.

Deepa Rajasekaran1, Sabine Gröning2, Corinna Schmitz3, Swen Zierow1, Natalie Drucker1, Maria Bakou4, Kristian Kohl4, André Mertens2, Hongqi Lue2, Christian Weber5, Annie Xiao6, Gary Luker6, Aphrodite Kapurniotu7, Elias Lolis8, Jürgen Bernhagen9.   

Abstract

An emerging number of non-chemokine mediators are found to bind to classical chemokine receptors and to elicit critical biological responses. Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine that exhibits chemokine-like activities through non-cognate interactions with the chemokine receptors CXCR2 and CXCR4, in addition to activating the type II receptor CD74. Activation of the MIF-CXCR2 and -CXCR4 axes promotes leukocyte recruitment, mediating the exacerbating role of MIF in atherosclerosis and contributing to the wealth of other MIF biological activities. Although the structural basis of the MIF-CXCR2 interaction has been well studied and was found to engage a pseudo-ELR and an N-like loop motif, nothing is known about the regions of CXCR4 and MIF that are involved in binding to each other. Using a genetic strain of Saccharomyces cerevisiae that expresses a functional CXCR4 receptor, site-specific mutagenesis, hybrid CXCR3/CXCR4 receptors, pharmacological reagents, peptide array analysis, chemotaxis, fluorescence spectroscopy, and circular dichroism, we provide novel molecular information about the structural elements that govern the interaction between MIF and CXCR4. The data identify similarities with classical chemokine-receptor interactions but also provide evidence for a partial allosteric agonist compared with CXCL12 that is possible due to the two binding sites of CXCR4.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein-coupled receptor (GPCR); chemokine; cytokine; protein mapping; protein-protein interaction; structure-function

Mesh:

Substances:

Year:  2016        PMID: 27226569      PMCID: PMC4957068          DOI: 10.1074/jbc.M116.717751

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  87 in total

1.  Two distinct cytokines released from a human aminoacyl-tRNA synthetase.

Authors:  K Wakasugi; P Schimmel
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

Review 2.  Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery.

Authors:  E Lolis
Journal:  Curr Opin Pharmacol       Date:  2001-12       Impact factor: 5.547

3.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.

Authors:  E Oberlin; A Amara; F Bachelerie; C Bessia; J L Virelizier; F Arenzana-Seisdedos; O Schwartz; J M Heard; I Clark-Lewis; D F Legler; M Loetscher; M Baggiolini; B Moser
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

4.  Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis.

Authors:  Anke Burger-Kentischer; Heike Goebel; Rüdiger Seiler; Gustav Fraedrich; Hans E Schaefer; Stefanie Dimmeler; Robert Kleemann; Jürgen Bernhagen; Christian Ihling
Journal:  Circulation       Date:  2002-04-02       Impact factor: 29.690

5.  MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism.

Authors:  Sandra Kraemer; Hongqi Lue; Alma Zernecke; Aphrodite Kapurniotu; Erika Andreetto; Ronald Frank; Birgitt Lennartz; Christian Weber; Jürgen Bernhagen
Journal:  FASEB J       Date:  2010-11-24       Impact factor: 5.191

6.  Imaging CXCR4 signaling with firefly luciferase complementation.

Authors:  Kathryn E Luker; Mudit Gupta; Gary D Luker
Journal:  Anal Chem       Date:  2008-06-06       Impact factor: 6.986

7.  Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase.

Authors:  R Kleemann; A Kapurniotu; R W Frank; A Gessner; R Mischke; O Flieger; S Jüttner; H Brunner; J Bernhagen
Journal:  J Mol Biol       Date:  1998-07-03       Impact factor: 5.469

8.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

9.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

10.  A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.

Authors:  Michael A McDevitt; Jianlin Xie; Shanmugasundaram Ganapathy-Kanniappan; Ganapathy Shanmugasundaram; Jason Griffith; Aihua Liu; Courtney McDonald; Philip Thuma; Victor R Gordeuk; Christine N Metz; Robert Mitchell; Jeffrey Keefer; John David; Lin Leng; Richard Bucala
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

View more
  29 in total

1.  Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.

Authors:  Amanda Sparkes; Patrick De Baetselier; Lea Brys; Inês Cabrito; Yann G-J Sterckx; Steve Schoonooghe; Serge Muyldermans; Geert Raes; Richard Bucala; Peter Vanlandschoot; Jo A Van Ginderachter; Benoît Stijlemans
Journal:  FASEB J       Date:  2018-01-25       Impact factor: 5.191

2.  "Remote" myokine protects from pulmonary ischemia/reperfusion injury by a surprising "proximal" control mechanism.

Authors:  Jürgen Bernhagen
Journal:  Ann Transl Med       Date:  2018-07

Review 3.  Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Authors:  Philip M Murphy; Lauren Heusinkveld
Journal:  Cytokine       Date:  2018-02-15       Impact factor: 3.861

4.  Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; William L Jorgensen
Journal:  J Med Chem       Date:  2018-06-04       Impact factor: 7.446

5.  Regulation of MIF Enzymatic Activity by an Allosteric Site at the Central Solvent Channel.

Authors:  Georgios Pantouris; Leepakshi Khurana; Anthony Ma; Erin Skeens; Krystle Reiss; Victor S Batista; George P Lisi; Elias J Lolis
Journal:  Cell Chem Biol       Date:  2020-05-19       Impact factor: 8.116

6.  Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.

Authors:  Corinna Schmitz; Heidi Noels; Omar El Bounkari; Eva Straussfeld; Remco T A Megens; Marieke Sternkopf; Setareh Alampour-Rajabi; Christine Krammer; Pathricia V Tilstam; Norbert Gerdes; Christina Bürger; Aphrodite Kapurniotu; Richard Bucala; Joachim Jankowski; Christian Weber; Jürgen Bernhagen
Journal:  FASEB J       Date:  2018-03-15       Impact factor: 5.191

7.  Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery.

Authors:  In Heon Lee; Matthew S Palombo; Xiaoping Zhang; Zoltan Szekely; Patrick J Sinko
Journal:  Eur J Pharm Biopharm       Date:  2018-06-09       Impact factor: 5.571

8.  Cross-kingdom mimicry of the receptor signaling and leukocyte recruitment activity of a human cytokine by its plant orthologs.

Authors:  Dzmitry Sinitski; Katrin Gruner; Markus Brandhofer; Christos Kontos; Pascal Winkler; Anja Reinstädler; Priscila Bourilhon; Zhangping Xiao; Robbert Cool; Aphrodite Kapurniotu; Frank J Dekker; Ralph Panstruga; Jürgen Bernhagen
Journal:  J Biol Chem       Date:  2019-12-06       Impact factor: 5.486

Review 9.  CXCL12 Signaling in the Tumor Microenvironment.

Authors:  Luigi Portella; Anna Maria Bello; Stefania Scala
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.

Authors:  Gary D Luker; Jinming Yang; Ann Richmond; Stefania Scala; Claudio Festuccia; Margret Schottelius; Hans-Jürgen Wester; Johann Zimmermann
Journal:  J Leukoc Biol       Date:  2020-10-26       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.